Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation

In order to understand and possibly treat B-cell malignancies associated with latent gammaherpesvirus infection, it is vital to understand the factors that control the balance between the two transcriptional states of gammaherpesviruses: latency and lytic replication. We used murine gammaherpesvirus...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of virology 2014-09, Vol.88 (17), p.10002-10012
Hauptverfasser: Haas, Florian, Yamauchi, Kazuma, Murat, Monika, Bernasconi, Michele, Yamanaka, Noboru, Speck, Roberto F, Nadal, David
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10012
container_issue 17
container_start_page 10002
container_title Journal of virology
container_volume 88
creator Haas, Florian
Yamauchi, Kazuma
Murat, Monika
Bernasconi, Michele
Yamanaka, Noboru
Speck, Roberto F
Nadal, David
description In order to understand and possibly treat B-cell malignancies associated with latent gammaherpesvirus infection, it is vital to understand the factors that control the balance between the two transcriptional states of gammaherpesviruses: latency and lytic replication. We used murine gammaherpesvirus 68 (MHV 68) as a model system to investigate how engagement of endosomal Toll-like receptors (TLRs) impacts reactivation from latency in vitro and establishment of latent infection in vivo. We found that treatment with TLR7 ligand R848 or TLR9 ligand CpG oligodeoxynucleotide (ODN) suppresses reactivation of MHV 68 in vitro. These suppressive effects correlated with the ability to activate cellular transcription factor NF-κB. Downregulation of TLR9 by RNA interference in vitro led to a reduction of nuclear levels of NF-κB p65 and consequently to an increase of spontaneous reactivation in cells latently infected with MHV 68, indicating that the TLR9 pathway suppresses spontaneous reactivation events. In vivo, sustained stimulation of TLR7 by repeated R848 treatment led to an increased frequency of infected splenocytes compared to mock-treated control results. Frequencies of infected splenic B cells in tlr7-/- or tlr9-/- mice after establishment of latency did not differ from those seen with their wild-type counterparts. Nevertheless, MHV 68-infected B cells from tlr9-/- mice showed a higher frequency of reactivation than B cells from wild-type or tlr7-/- mice in ex vivo reactivation assays. Thus, we show a suppressive effect of TLR7 or TLR9 triggering on MHV 68 reactivation that correlates with NF-κB activation and that the mere presence of a functional TLR9 signaling pathway contributes to dampen lytic gammaherpesvirus reactivation in infected cells. A hallmark of gammaherpesviruses is their establishment of latency in B cells that is reversible through lytic reactivation. Latency can result in B-cell malignancies. Activation of the innate immune system is thought to contribute to controlling the switch between the transcriptional states of latency and reactivation. Nevertheless, the mechanisms involved are not clear. Here, we show that engagement of Toll-like receptor 7 (TLR7) and TLR9 suppresses reactivation of murine gammaherpesvirus MHV 68 in vitro and that stimulation of TLR7 in vivo increases the frequency of infected cells. TLR7 and TLR9 are innate immunity sensors of nucleic acids localized in endosomes. Additionally, we demonstrate that impairment of TL
doi_str_mv 10.1128/JVI.01486-14
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4136310</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1551609328</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-c180e4414081d6fc322b3d6c5e38abf53bd9d8864e75d51cd1774394c77bdcb33</originalsourceid><addsrcrecordid>eNqNkc1u1TAQhS1ERS-FHWvkZZFI64l_4myQSkVLqyuQ0AWxsxx7Qg1JHOzkSrwaD9FnamjLVdmxmiPNN2dmdAh5AewIoNTHl18ujhgIrQoQj8gKWK0LKUE8JivGyrKQXH_dJ09z_s4WTCjxhOyXohal1HxFphM3ha2dQhxobOmHs-L691u6DZbi4GOOve3oJnZd0YUfSBM6HKeYaEUPN-tP1Su66EXUNM_jmDBnzLSfUxiQXmEaMW9DmjNVehm1u03PyF5ru4zP7-sB-Xz2bnP6vlh_PL84PVkXTkA1FQ40QyFAMA1etY6XZcO9chK5tk0reeNrr7USWEkvwXmoKsFr4aqq8a7h_IC8ufMd56ZH73CYku3MmEJv0y8TbTD_doZwZb7FrRHAFQe2GBzeG6T4c8Y8mT5kh11nB4xzNiCV0oJr-T-oBMVqXuoFfX2HuhRzTtjuLgJm_mRqlkzNbaYGxIK_fPjFDv4bIr8BMHKdgw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1551609328</pqid></control><display><type>article</type><title>Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Haas, Florian ; Yamauchi, Kazuma ; Murat, Monika ; Bernasconi, Michele ; Yamanaka, Noboru ; Speck, Roberto F ; Nadal, David</creator><contributor>Longnecker, R. M.</contributor><creatorcontrib>Haas, Florian ; Yamauchi, Kazuma ; Murat, Monika ; Bernasconi, Michele ; Yamanaka, Noboru ; Speck, Roberto F ; Nadal, David ; Longnecker, R. M.</creatorcontrib><description>In order to understand and possibly treat B-cell malignancies associated with latent gammaherpesvirus infection, it is vital to understand the factors that control the balance between the two transcriptional states of gammaherpesviruses: latency and lytic replication. We used murine gammaherpesvirus 68 (MHV 68) as a model system to investigate how engagement of endosomal Toll-like receptors (TLRs) impacts reactivation from latency in vitro and establishment of latent infection in vivo. We found that treatment with TLR7 ligand R848 or TLR9 ligand CpG oligodeoxynucleotide (ODN) suppresses reactivation of MHV 68 in vitro. These suppressive effects correlated with the ability to activate cellular transcription factor NF-κB. Downregulation of TLR9 by RNA interference in vitro led to a reduction of nuclear levels of NF-κB p65 and consequently to an increase of spontaneous reactivation in cells latently infected with MHV 68, indicating that the TLR9 pathway suppresses spontaneous reactivation events. In vivo, sustained stimulation of TLR7 by repeated R848 treatment led to an increased frequency of infected splenocytes compared to mock-treated control results. Frequencies of infected splenic B cells in tlr7-/- or tlr9-/- mice after establishment of latency did not differ from those seen with their wild-type counterparts. Nevertheless, MHV 68-infected B cells from tlr9-/- mice showed a higher frequency of reactivation than B cells from wild-type or tlr7-/- mice in ex vivo reactivation assays. Thus, we show a suppressive effect of TLR7 or TLR9 triggering on MHV 68 reactivation that correlates with NF-κB activation and that the mere presence of a functional TLR9 signaling pathway contributes to dampen lytic gammaherpesvirus reactivation in infected cells. A hallmark of gammaherpesviruses is their establishment of latency in B cells that is reversible through lytic reactivation. Latency can result in B-cell malignancies. Activation of the innate immune system is thought to contribute to controlling the switch between the transcriptional states of latency and reactivation. Nevertheless, the mechanisms involved are not clear. Here, we show that engagement of Toll-like receptor 7 (TLR7) and TLR9 suppresses reactivation of murine gammaherpesvirus MHV 68 in vitro and that stimulation of TLR7 in vivo increases the frequency of infected cells. TLR7 and TLR9 are innate immunity sensors of nucleic acids localized in endosomes. Additionally, we demonstrate that impairment of TLR9 signaling in latently infected B cells leads to increased reactivation. Thus, activated endosomal TLR7 and TLR9 pathways play an important role in promoting establishment of latent gammaherpesvirus infection. Counteracting signaling of these pathways allows reactivation and could represent treatment targets in gammaherpesvirus-associated malignancies.</description><identifier>ISSN: 0022-538X</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/JVI.01486-14</identifier><identifier>PMID: 24942583</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Animals ; Gammaherpesvirus ; Herpesviridae Infections - immunology ; Herpesviridae Infections - virology ; Membrane Glycoproteins - immunology ; Mice, Inbred C57BL ; Murine gammaherpesvirus ; Murine gammaherpesvirus 68 ; Murine herpesvirus ; NF-kappa B - immunology ; Pathogenesis and Immunity ; Rhadinovirus - immunology ; Rhadinovirus - physiology ; Toll-Like Receptor 7 - immunology ; Toll-Like Receptor 9 - immunology ; Tumor Virus Infections - immunology ; Tumor Virus Infections - virology ; Virus Activation ; Virus Latency</subject><ispartof>Journal of virology, 2014-09, Vol.88 (17), p.10002-10012</ispartof><rights>Copyright © 2014, American Society for Microbiology. All Rights Reserved.</rights><rights>Copyright © 2014, American Society for Microbiology. All Rights Reserved. 2014 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-c180e4414081d6fc322b3d6c5e38abf53bd9d8864e75d51cd1774394c77bdcb33</citedby><cites>FETCH-LOGICAL-c417t-c180e4414081d6fc322b3d6c5e38abf53bd9d8864e75d51cd1774394c77bdcb33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136310/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136310/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24942583$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Longnecker, R. M.</contributor><creatorcontrib>Haas, Florian</creatorcontrib><creatorcontrib>Yamauchi, Kazuma</creatorcontrib><creatorcontrib>Murat, Monika</creatorcontrib><creatorcontrib>Bernasconi, Michele</creatorcontrib><creatorcontrib>Yamanaka, Noboru</creatorcontrib><creatorcontrib>Speck, Roberto F</creatorcontrib><creatorcontrib>Nadal, David</creatorcontrib><title>Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation</title><title>Journal of virology</title><addtitle>J Virol</addtitle><description>In order to understand and possibly treat B-cell malignancies associated with latent gammaherpesvirus infection, it is vital to understand the factors that control the balance between the two transcriptional states of gammaherpesviruses: latency and lytic replication. We used murine gammaherpesvirus 68 (MHV 68) as a model system to investigate how engagement of endosomal Toll-like receptors (TLRs) impacts reactivation from latency in vitro and establishment of latent infection in vivo. We found that treatment with TLR7 ligand R848 or TLR9 ligand CpG oligodeoxynucleotide (ODN) suppresses reactivation of MHV 68 in vitro. These suppressive effects correlated with the ability to activate cellular transcription factor NF-κB. Downregulation of TLR9 by RNA interference in vitro led to a reduction of nuclear levels of NF-κB p65 and consequently to an increase of spontaneous reactivation in cells latently infected with MHV 68, indicating that the TLR9 pathway suppresses spontaneous reactivation events. In vivo, sustained stimulation of TLR7 by repeated R848 treatment led to an increased frequency of infected splenocytes compared to mock-treated control results. Frequencies of infected splenic B cells in tlr7-/- or tlr9-/- mice after establishment of latency did not differ from those seen with their wild-type counterparts. Nevertheless, MHV 68-infected B cells from tlr9-/- mice showed a higher frequency of reactivation than B cells from wild-type or tlr7-/- mice in ex vivo reactivation assays. Thus, we show a suppressive effect of TLR7 or TLR9 triggering on MHV 68 reactivation that correlates with NF-κB activation and that the mere presence of a functional TLR9 signaling pathway contributes to dampen lytic gammaherpesvirus reactivation in infected cells. A hallmark of gammaherpesviruses is their establishment of latency in B cells that is reversible through lytic reactivation. Latency can result in B-cell malignancies. Activation of the innate immune system is thought to contribute to controlling the switch between the transcriptional states of latency and reactivation. Nevertheless, the mechanisms involved are not clear. Here, we show that engagement of Toll-like receptor 7 (TLR7) and TLR9 suppresses reactivation of murine gammaherpesvirus MHV 68 in vitro and that stimulation of TLR7 in vivo increases the frequency of infected cells. TLR7 and TLR9 are innate immunity sensors of nucleic acids localized in endosomes. Additionally, we demonstrate that impairment of TLR9 signaling in latently infected B cells leads to increased reactivation. Thus, activated endosomal TLR7 and TLR9 pathways play an important role in promoting establishment of latent gammaherpesvirus infection. Counteracting signaling of these pathways allows reactivation and could represent treatment targets in gammaherpesvirus-associated malignancies.</description><subject>Animals</subject><subject>Gammaherpesvirus</subject><subject>Herpesviridae Infections - immunology</subject><subject>Herpesviridae Infections - virology</subject><subject>Membrane Glycoproteins - immunology</subject><subject>Mice, Inbred C57BL</subject><subject>Murine gammaherpesvirus</subject><subject>Murine gammaherpesvirus 68</subject><subject>Murine herpesvirus</subject><subject>NF-kappa B - immunology</subject><subject>Pathogenesis and Immunity</subject><subject>Rhadinovirus - immunology</subject><subject>Rhadinovirus - physiology</subject><subject>Toll-Like Receptor 7 - immunology</subject><subject>Toll-Like Receptor 9 - immunology</subject><subject>Tumor Virus Infections - immunology</subject><subject>Tumor Virus Infections - virology</subject><subject>Virus Activation</subject><subject>Virus Latency</subject><issn>0022-538X</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u1TAQhS1ERS-FHWvkZZFI64l_4myQSkVLqyuQ0AWxsxx7Qg1JHOzkSrwaD9FnamjLVdmxmiPNN2dmdAh5AewIoNTHl18ujhgIrQoQj8gKWK0LKUE8JivGyrKQXH_dJ09z_s4WTCjxhOyXohal1HxFphM3ha2dQhxobOmHs-L691u6DZbi4GOOve3oJnZd0YUfSBM6HKeYaEUPN-tP1Su66EXUNM_jmDBnzLSfUxiQXmEaMW9DmjNVehm1u03PyF5ru4zP7-sB-Xz2bnP6vlh_PL84PVkXTkA1FQ40QyFAMA1etY6XZcO9chK5tk0reeNrr7USWEkvwXmoKsFr4aqq8a7h_IC8ufMd56ZH73CYku3MmEJv0y8TbTD_doZwZb7FrRHAFQe2GBzeG6T4c8Y8mT5kh11nB4xzNiCV0oJr-T-oBMVqXuoFfX2HuhRzTtjuLgJm_mRqlkzNbaYGxIK_fPjFDv4bIr8BMHKdgw</recordid><startdate>20140901</startdate><enddate>20140901</enddate><creator>Haas, Florian</creator><creator>Yamauchi, Kazuma</creator><creator>Murat, Monika</creator><creator>Bernasconi, Michele</creator><creator>Yamanaka, Noboru</creator><creator>Speck, Roberto F</creator><creator>Nadal, David</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20140901</creationdate><title>Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation</title><author>Haas, Florian ; Yamauchi, Kazuma ; Murat, Monika ; Bernasconi, Michele ; Yamanaka, Noboru ; Speck, Roberto F ; Nadal, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-c180e4414081d6fc322b3d6c5e38abf53bd9d8864e75d51cd1774394c77bdcb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Gammaherpesvirus</topic><topic>Herpesviridae Infections - immunology</topic><topic>Herpesviridae Infections - virology</topic><topic>Membrane Glycoproteins - immunology</topic><topic>Mice, Inbred C57BL</topic><topic>Murine gammaherpesvirus</topic><topic>Murine gammaherpesvirus 68</topic><topic>Murine herpesvirus</topic><topic>NF-kappa B - immunology</topic><topic>Pathogenesis and Immunity</topic><topic>Rhadinovirus - immunology</topic><topic>Rhadinovirus - physiology</topic><topic>Toll-Like Receptor 7 - immunology</topic><topic>Toll-Like Receptor 9 - immunology</topic><topic>Tumor Virus Infections - immunology</topic><topic>Tumor Virus Infections - virology</topic><topic>Virus Activation</topic><topic>Virus Latency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haas, Florian</creatorcontrib><creatorcontrib>Yamauchi, Kazuma</creatorcontrib><creatorcontrib>Murat, Monika</creatorcontrib><creatorcontrib>Bernasconi, Michele</creatorcontrib><creatorcontrib>Yamanaka, Noboru</creatorcontrib><creatorcontrib>Speck, Roberto F</creatorcontrib><creatorcontrib>Nadal, David</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haas, Florian</au><au>Yamauchi, Kazuma</au><au>Murat, Monika</au><au>Bernasconi, Michele</au><au>Yamanaka, Noboru</au><au>Speck, Roberto F</au><au>Nadal, David</au><au>Longnecker, R. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation</atitle><jtitle>Journal of virology</jtitle><addtitle>J Virol</addtitle><date>2014-09-01</date><risdate>2014</risdate><volume>88</volume><issue>17</issue><spage>10002</spage><epage>10012</epage><pages>10002-10012</pages><issn>0022-538X</issn><eissn>1098-5514</eissn><abstract>In order to understand and possibly treat B-cell malignancies associated with latent gammaherpesvirus infection, it is vital to understand the factors that control the balance between the two transcriptional states of gammaherpesviruses: latency and lytic replication. We used murine gammaherpesvirus 68 (MHV 68) as a model system to investigate how engagement of endosomal Toll-like receptors (TLRs) impacts reactivation from latency in vitro and establishment of latent infection in vivo. We found that treatment with TLR7 ligand R848 or TLR9 ligand CpG oligodeoxynucleotide (ODN) suppresses reactivation of MHV 68 in vitro. These suppressive effects correlated with the ability to activate cellular transcription factor NF-κB. Downregulation of TLR9 by RNA interference in vitro led to a reduction of nuclear levels of NF-κB p65 and consequently to an increase of spontaneous reactivation in cells latently infected with MHV 68, indicating that the TLR9 pathway suppresses spontaneous reactivation events. In vivo, sustained stimulation of TLR7 by repeated R848 treatment led to an increased frequency of infected splenocytes compared to mock-treated control results. Frequencies of infected splenic B cells in tlr7-/- or tlr9-/- mice after establishment of latency did not differ from those seen with their wild-type counterparts. Nevertheless, MHV 68-infected B cells from tlr9-/- mice showed a higher frequency of reactivation than B cells from wild-type or tlr7-/- mice in ex vivo reactivation assays. Thus, we show a suppressive effect of TLR7 or TLR9 triggering on MHV 68 reactivation that correlates with NF-κB activation and that the mere presence of a functional TLR9 signaling pathway contributes to dampen lytic gammaherpesvirus reactivation in infected cells. A hallmark of gammaherpesviruses is their establishment of latency in B cells that is reversible through lytic reactivation. Latency can result in B-cell malignancies. Activation of the innate immune system is thought to contribute to controlling the switch between the transcriptional states of latency and reactivation. Nevertheless, the mechanisms involved are not clear. Here, we show that engagement of Toll-like receptor 7 (TLR7) and TLR9 suppresses reactivation of murine gammaherpesvirus MHV 68 in vitro and that stimulation of TLR7 in vivo increases the frequency of infected cells. TLR7 and TLR9 are innate immunity sensors of nucleic acids localized in endosomes. Additionally, we demonstrate that impairment of TLR9 signaling in latently infected B cells leads to increased reactivation. Thus, activated endosomal TLR7 and TLR9 pathways play an important role in promoting establishment of latent gammaherpesvirus infection. Counteracting signaling of these pathways allows reactivation and could represent treatment targets in gammaherpesvirus-associated malignancies.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>24942583</pmid><doi>10.1128/JVI.01486-14</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-538X
ispartof Journal of virology, 2014-09, Vol.88 (17), p.10002-10012
issn 0022-538X
1098-5514
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4136310
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Animals
Gammaherpesvirus
Herpesviridae Infections - immunology
Herpesviridae Infections - virology
Membrane Glycoproteins - immunology
Mice, Inbred C57BL
Murine gammaherpesvirus
Murine gammaherpesvirus 68
Murine herpesvirus
NF-kappa B - immunology
Pathogenesis and Immunity
Rhadinovirus - immunology
Rhadinovirus - physiology
Toll-Like Receptor 7 - immunology
Toll-Like Receptor 9 - immunology
Tumor Virus Infections - immunology
Tumor Virus Infections - virology
Virus Activation
Virus Latency
title Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T10%3A50%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20NF-%CE%BAB%20via%20endosomal%20Toll-like%20receptor%207%20(TLR7)%20or%20TLR9%20suppresses%20murine%20herpesvirus%2068%20reactivation&rft.jtitle=Journal%20of%20virology&rft.au=Haas,%20Florian&rft.date=2014-09-01&rft.volume=88&rft.issue=17&rft.spage=10002&rft.epage=10012&rft.pages=10002-10012&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/JVI.01486-14&rft_dat=%3Cproquest_pubme%3E1551609328%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1551609328&rft_id=info:pmid/24942583&rfr_iscdi=true